Replies to post #494887 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

I did point out that pridopidine would be an important candidate to keep an eye one and why.

[boi568]

CORRECTION: My post regarding Pridopidine confused its ALS trial results with its HD results. Just ignore the prior post. My apologies.

[sab63090]

boi568
Certainly above my head, but thanks for the explanation!

[Bourbon_on_my_cornflakes]

Hmm that is not encouraging.
Thanks for posting.
Is Huntington's D a big problem (large number of patients?)

[WilliamMunny]

As a holder of AVXL, I am glad to have it reconfirmed that not all SIGMAR1 agonists are created equal. As to efficacy, Blarcamesine beat the SOC, LEQEMBI and Kisunla, (not to mention safety, cost, and practical delivery).